Itraconazole Powder

DRUG2 trials

Sponsors

Pulmatrix Inc.

Conditions

ABPAAsthma

Phase 1

Safety, Tolerability and Pharmacokinetics of PUR1900 (Itraconazole Powder) in Healthy Volunteers and Adults With Asthma

CompletedNCT03479411

Pulmatrix Inc.Asthma

Start: 2018-02-09End: 2018-06-28Updated: 2018-07-27

Phase 2

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

TerminatedNCT05667662

Pulmatrix Inc.ABPA

Start: 2023-02-01End: 2024-02-27Updated: 2024-04-02

Related Papers

Evaluation of the Potential for Drug-Drug Interactions with Inhaled Itraconazole Using Physiologically Based Pharmacokinetic Modelling, Based on Phase 1 Clinical Data

The AAPS Journal2023-06-216 citations